Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Blueberries MedicalBBRRF -9.37% Equity-to-Asset is 0.04 as of Jun. 2026, which is 91% below its 10-year median of 0.46. The stock has 1 warning sign investors should review. Among 1,007 Drug Manufacturers companies, Blueberries Medical ranks worse than 91.46% on this metric.
Equity to Asset ratio is calculated as total stockholders equity divided by total asset. Blueberries Medical's Total Stockholders Equity for the quarter that ended in Jun. 2026 was $0.02 Mil. Blueberries Medical's Total Assets for the quarter that ended in Jun. 2026 was $0.48 Mil.
Therefore, Blueberries Medical's Equity to Asset Ratio for the quarter that ended in Jun. 2026 was 0.04.
The historical rank and industry rank for Blueberries Medical's Equity-to-Asset or its related term are showing as below:
BBRRF'
s Equity-to-Asset Range Over the Past 10 Years
Min: -336 Med: 0.46 Max: 0.93
Current: 0.04
During the past 13 years, the highest Equity to Asset Ratio of Blueberries Medical was 0.93. The lowest was -336.00. And the median was 0.46.
BBRRF's Equity-to-Asset is ranked worse than 91.46% of 1007
companies
in the Drug Manufacturers industry
Industry Median: 0.6
vs BBRRF: 0.04
Blueberries Medical (OTCPK:BBRRF) Equity-to-Asset Explanation
Equity to Asset ratio can vary greatly across different industries, as they have different capital structure. A company with smaller Equity to Asset ratio (more leveraged) may have higher ROE % because of the leverage.
For banks, the required minimum Equity to Asset ratio by regulation is 5%. Some stronger banks may have Equity to Asset Ratio of more than 10%.
Blueberries Medical Equity-to-Asset Related Terms
Blueberries Medical Equity-to-Asset Historical Data
* Premium members only.
The historical data trend for Blueberries Medical's Equity-to-Asset can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Blueberries Medical's Equity-to-Asset, along with its competitors' market caps and Equity-to-Asset data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Blueberries Medical Equity-to-Asset vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Blueberries Medical's Equity-to-Asset distribution charts can be found below:
* The bar in red indicates where Blueberries Medical's Equity-to-Asset falls into.
Equity to Asset ratio measures the ratios of the portion of the asset owned by shareholders out of the total asset. It indicates the leverage of the company, and the amount of debt the company uses in its operation.
Equity to Asset ratio is calculated by dividing total stockholders equity by total asset.
Blueberries Medical's Equity to Asset Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Blueberries Medical (BBRRF) has a Equity-to-Asset of 0.04 as of Jun. 2026. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Blueberries Medical and its competitors. This is 91% below median its historical median of 0.46. According to the industry distribution chart, Blueberries Medical ranks #921 out of 1007 companies in the Drug Manufacturers industry, placing it in the top 91.5%.
Is Blueberries Medical's Equity-to-Asset too high?
Blueberries Medical's current Equity-to-Asset of 0.04 is 91% below median its 10-year median of 0.46. The Drug Manufacturers industry median Equity-to-Asset is 0.60. Blueberries Medical's value of 0.04 is 93.3% below this industry median. Based on the distribution chart, Blueberries Medical ranks #921 out of 1007 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers.
How does Blueberries Medical's Equity-to-Asset compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Blueberries Medical ranks #921 out of 1007 companies for Equity-to-Asset. This places Blueberries Medical in the lower half of its industry. The industry median Equity-to-Asset is 0.60. Blueberries Medical's value of 0.04 is 93.3% below this benchmark. While the company's 10-year median is 0.46 vs. the industry median of 0.60, Blueberries Medical has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Equity-to-Asset for a Drug Manufacturers company?
The median Equity-to-Asset among Drug Manufacturers companies is 0.60, based on 1,007 companies in the industry. Companies in the top quartile (top 25%) have a Equity-to-Asset significantly above this median, while those in the bottom quartile fall well below. However, Equity-to-Asset should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Blueberries Medical's current Equity-to-Asset of 0.04 is 93.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Equity-to-Asset mean?
A high Equity-to-Asset can signal that a stock is expensive relative to its fundamentals. Equity-to-asset ratio equals total company equity divided by total assets. It measures financial leverage. View historical data on Blueberries Medical and its competitors. For the Drug Manufacturers industry, the median Equity-to-Asset is 0.60 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Blueberries Medical's current Equity-to-Asset is 0.04, which is 91% below median its own 10-year median of 0.46. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Blueberries Medical stock overvalued right now?
Blueberries Medical (BBRRF) has a current Equity-to-Asset of 0.04. The current Equity-to-Asset is 0.04, which is 91% below median its 10-year median of 0.46 and 93.3% below the Drug Manufacturers industry median of 0.60. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Equity-to-Asset calculated?
Equity-to-Asset is calculated from a company's financial statements. For Blueberries Medical (BBRRF), the current Equity-to-Asset is 0.04 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Blueberries Medical Corp is a consumer science company focused on health, wellness and longevity. The company also distributes functional supplements, wellness products, and natural ingredients. It cultivates, produces, and distributes cannabidiol (CBD) and THC (tetrahydrocannabinol) based medical cannabis domestically as well as internationally. The company generates all of its revenues from Colombia.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BBRRF has been successfully added to your 
